Orthopediatrics (KIDS) Research & Development (2016 - 2026)

Orthopediatrics' Research & Development history runs 11 years deep, the most recent figure standing at $2.2 million for Q1 2026.

• In Q1 2026, Research & Development fell 5.1% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $9.0 million (down 13.53% YoY), while the FY2025 annual figure was $9.1 million, down 17.51% from the prior year.
• Research & Development was $2.2 million for Q1 2026 at Orthopediatrics, down from $2.3 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $3.0 million in Q1 2024 to a low of $1.7 million in Q2 2022.
• Historically, Research & Development has averaged $2.5 million across 5 years, with a median of $2.4 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Research & Development soared 69.78% in 2023, then dropped 22.53% in 2025.
• A 5-year view of Research & Development shows it stood at $2.5 million in 2022, then advanced by 18.2% to $2.9 million in 2023, then fell by 0.21% to $2.9 million in 2024, then decreased by 22.53% to $2.3 million in 2025, then retreated by 1.24% to $2.2 million in 2026.
• The last three Research & Development figures came in at $2.2 million (Q1 2026), $2.3 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.